SYK Add to watchlist $279.22 3.39 (-1.20%) Last updated: Oct 13, 2026 14:28
52-Week Range
$279.22
$267.00 $279.22 $392.55

Fundamentals Overview

Stryker Corporation is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 28.8 PEG 2.62 P/B 5.03 P/S 4.15

Profitability

ROE 16.36% Net margin 14.4%

Risk (Beta)

0.79 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 57% confidence Risk: Lower Volatility — Beta 0.79. Diversify and only invest what you can afford to lose.

Pressures (Sell):

PEG 2.62 · Volume below average

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$108.40B
P/E (TTM)
28.78
EPS (TTM)
N/A
Dividend Yield
1.02%
52-Week Range
$267.00 - $392.55
Volume vs Avg
0.13x
13% of avg (Low)
Beta
0.79

About

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipmen...
Sector: Healthcare
Headquarters: US
Beta: 0.79 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) 28.78
PEG (TTM) 2.62
P/B (TTM) 5.03
P/S (TTM) 4.15
Profitability
ROE (TTM) 16.36%
ROA (TTM) 7.89%
Revenue growth (YoY) N/A
Net margin (TTM) 14.43%
Gross margin (TTM) 65.31%
Operating margin (TTM) 21.32%
Debt to equity (TTM) 0.62

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for SYK.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.